Michelle Taylor

1.5k total citations
41 papers, 1.1k citations indexed

About

Michelle Taylor is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Michelle Taylor has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Cellular and Molecular Neuroscience and 4 papers in Genetics. Recurrent topics in Michelle Taylor's work include Receptor Mechanisms and Signaling (28 papers), Neurotransmitter Receptor Influence on Behavior (18 papers) and Neuropeptides and Animal Physiology (14 papers). Michelle Taylor is often cited by papers focused on Receptor Mechanisms and Signaling (28 papers), Neurotransmitter Receptor Influence on Behavior (18 papers) and Neuropeptides and Animal Physiology (14 papers). Michelle Taylor collaborates with scholars based in United States and Germany. Michelle Taylor's co-authors include Robert R. Luedtke, Robert H. Mach, Amy Hauck Newman, Peter Grundt, Jinbin Xu, Zhude Tu, Jianjing Cao, Suwanna Vangveravong, David D. Ho and Suzy A. Griffin and has published in prestigious journals such as Diabetes, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Michelle Taylor

40 papers receiving 1.0k citations

Peers

Michelle Taylor
Meaghan Morris United States
Alice Jiang United States
Robert P. Compton United States
Cristian Salinas United Kingdom
Michelle Taylor
Citations per year, relative to Michelle Taylor Michelle Taylor (= 1×) peers Svetlana Leschiner

Countries citing papers authored by Michelle Taylor

Since Specialization
Citations

This map shows the geographic impact of Michelle Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Taylor more than expected).

Fields of papers citing papers by Michelle Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Taylor. The network helps show where Michelle Taylor may publish in the future.

Co-authorship network of co-authors of Michelle Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Taylor. A scholar is included among the top collaborators of Michelle Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Taylor. Michelle Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Ji Youn, et al.. (2024). In vitro characterization of [125I]HY-3-24, a selective ligand for the dopamine D3 receptor. Frontiers in Neuroscience. 18. 1380009–1380009.
2.
Gharagozloo, Marjan, Danny Galleguillos, Elias S. Sotirchos, et al.. (2023). The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives. Neurotherapeutics. 20(4). 1229–1240. 11 indexed citations
3.
Gharagozloo, Marjan, Matthew D. Smith, Elias S. Sotirchos, et al.. (2021). Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis. Neurotherapeutics. 18(3). 1834–1848. 27 indexed citations
4.
Gharagozloo, Marjan, Matthew D. Smith, Jing Jin, et al.. (2021). Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation. Acta Neuropathologica. 142(5). 899–915. 68 indexed citations
5.
Reilly, Sean W., Aladdin Riad, Chia‐Ju Hsieh, et al.. (2019). Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs). Journal of Medicinal Chemistry. 62(10). 5132–5147. 15 indexed citations
6.
Chen, Peng-Jen, Michelle Taylor, Suzy A. Griffin, et al.. (2019). Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 29(18). 2690–2694. 15 indexed citations
7.
Rangel‐Barajas, Claudia, et al.. (2014). Characterization of [3H]LS‐3‐134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand. Journal of Neurochemistry. 131(4). 418–431. 15 indexed citations
8.
Huang, Renqi, Suzy A. Griffin, Michelle Taylor, et al.. (2013). The Effect of SV 293, a D2 Dopamine Receptor-Selective Antagonist, on D2 Receptor-Mediated GIRK Channel Activation and Adenylyl Cyclase Inhibition. Pharmacology. 92(1-2). 84–89. 5 indexed citations
9.
Li, Aixiao, Qi Wang, Shihong Li, et al.. (2013). Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands. Bioorganic & Medicinal Chemistry. 21(11). 2988–2998. 13 indexed citations
10.
Vangveravong, Suwanna, Zhanbin Zhang, Michelle Taylor, et al.. (2011). Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound. Bioorganic & Medicinal Chemistry. 19(11). 3502–3511. 43 indexed citations
11.
Mach, Robert H., Zhude Tu, Jinbin Xu, et al.. (2010). Endogenous dopamine (DA) competes with the binding of a radiolabeled D3receptor partial agonist in vivo: A positron emission tomography study. Synapse. 65(8). 724–732. 35 indexed citations
12.
Vangveravong, Suwanna, Michelle Taylor, Jinbin Xu, et al.. (2010). Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626. Bioorganic & Medicinal Chemistry. 18(14). 5291–5300. 21 indexed citations
13.
Karimi, Morvarid, Stephen M. Moerlein, Tom O. Videen, et al.. (2010). Decreased striatal dopamine receptor binding in primary focal dystonia: A D2 or D3 defect?. Movement Disorders. 26(1). 100–106. 38 indexed citations
14.
Taylor, Michelle, Peter Grundt, Suzy A. Griffin, Amy Hauck Newman, & Robert R. Luedtke. (2009). Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways. Synapse. 64(3). 251–266. 20 indexed citations
15.
Taylor, Michelle, et al.. (2008). Pregnancy Loss after First Trimester Viability in Women with Sickle Cell Trait: A Preliminary Report. Southern Medical Journal. 101(2). 150–151. 6 indexed citations
16.
Grundt, Peter, et al.. (2006). Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR. Bioorganic & Medicinal Chemistry Letters. 17(3). 745–749. 35 indexed citations
17.
Taylor, Michelle, et al.. (2006). Pregnancy loss after first-trimester viability in women with sickle cell trait: Time for a reappraisal?. American Journal of Obstetrics and Gynecology. 194(6). 1604–1608. 26 indexed citations
18.
Vangveravong, Suwanna, Michelle Taylor, Jinbin Xu, et al.. (2005). Synthesis and characterization of selective dopamine D2 receptor antagonists. Bioorganic & Medicinal Chemistry. 14(3). 815–825. 36 indexed citations
19.
Chu, Wenhua, Zhude Tu, Jinbin Xu, et al.. (2004). Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry. 13(1). 77–87. 93 indexed citations
20.
Taylor, Michelle, et al.. (2004). Nulliparity and Duration of Pregnancy in Multiple Gestation. Obstetrics and Gynecology. 104(1). 110–113. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026